(-)-demecolcine decreases expression ISO RGD:1351872 6480464 Demecolcine results in decreased expression of NRN1 mRNA CTD PMID:23649840 (S)-nicotine decreases expression ISO RGD:1617544 6480464 Nicotine results in decreased expression of NRN1 mRNA CTD PMID:21955143 1,2-dimethylhydrazine decreases expression ISO RGD:1617544 6480464 1, 2-Dimethylhydrazine results in decreased expression of NRN1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1617544 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of NRN1 mRNA] CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1617544 6480464 Tetrachlorodibenzodioxin results in increased expression of NRN1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NRN1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617544 6480464 Tetrachlorodibenzodioxin affects the expression of NRN1 mRNA CTD PMID:21570461 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1351872 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:1617544 6480464 Methylcholanthrene results in increased expression of NRN1 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1617544 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of NRN1 exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO RGD:1617544 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of NRN1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1351872 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of NRN1 gene CTD PMID:31601247 5-azacytidine decreases expression ISO RGD:1351872 6480464 Azacitidine results in decreased expression of NRN1 mRNA CTD PMID:19194470 acrylamide decreases expression ISO RGD:1351872 6480464 Acrylamide results in decreased expression of NRN1 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:1617544 6480464 Aflatoxin B1 results in decreased expression of NRN1 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1351872 6480464 Aflatoxin B1 results in decreased methylation of NRN1 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1351872 6480464 Tretinoin results in increased expression of NRN1 mRNA CTD PMID:33167477 antirheumatic drug increases expression ISO RGD:1351872 6480464 Antirheumatic Agents results in increased expression of NRN1 mRNA CTD PMID:24449571 arsane increases response to substance ISO RGD:1351872 6480464 NRN1 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 arsenic atom increases response to substance ISO RGD:1351872 6480464 NRN1 mRNA results in increased susceptibility to Arsenic CTD PMID:17976673 arsenite(3-) increases methylation ISO RGD:1351872 6480464 arsenite results in increased methylation of NRN1 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression ISO RGD:1617544 6480464 Benzo(a)pyrene results in decreased expression of NRN1 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1351872 6480464 Benzo(a)pyrene affects the methylation of NRN1 5' UTR, Benzo(a)pyrene affects the methylation of NRN1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1351872 6480464 Benzo(a)pyrene results in increased methylation of NRN1 3' UTR CTD PMID:27901495 Benzo[ghi]perylene decreases expression ISO RGD:1617544 6480464 1, 12-benzoperylene results in decreased expression of NRN1 mRNA CTD PMID:26377693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NRN1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1351872 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA CTD PMID:28628672 bisphenol A decreases expression ISO RGD:1617544 6480464 bisphenol A results in decreased expression of NRN1 mRNA CTD PMID:25594700 cadmium dichloride affects expression ISO RGD:1617544 6480464 Cadmium Chloride affects the expression of NRN1 mRNA CTD PMID:18974090 carbon nanotube decreases expression ISO RGD:1617544 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1351872 6480464 CGP 52608 promotes the reaction [RORA protein binds to NRN1 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1617544 6480464 Chlordecone results in increased expression of NRN1 mRNA CTD PMID:33711761 cocaine decreases expression ISO RGD:1617544 6480464 Cocaine results in decreased expression of NRN1 mRNA CTD PMID:18355967 cocaine multiple interactions ISO RGD:1617544 6480464 FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NRN1 mRNA] CTD PMID:18355967 cyclosporin A decreases expression ISO RGD:1617544 6480464 Cyclosporine results in decreased expression of NRN1 mRNA CTD PMID:19770486 dexamethasone increases expression ISO RGD:1617544 6480464 Dexamethasone results in increased expression of NRN1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1351872 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA CTD PMID:28628672 dioxygen multiple interactions ISO RGD:1351872 6480464 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... CTD PMID:24403227 dioxygen multiple interactions ISO RGD:1617544 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRN1 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1351872 6480464 Oxygen deficiency results in increased expression of NRN1 mRNA CTD PMID:24236059 , PMID:24403227 disodium selenite increases expression ISO RGD:1351872 6480464 Sodium Selenite results in increased expression of NRN1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1351872 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRN1 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:1351872 6480464 entinostat results in decreased expression of NRN1 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1617544 6480464 Ethanol results in increased expression of NRN1 mRNA CTD PMID:21955143 ethanol affects splicing ISO RGD:1617544 6480464 Ethanol affects the splicing of NRN1 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1351872 6480464 Ethyl Methanesulfonate results in decreased expression of NRN1 mRNA CTD PMID:23649840 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of NRN1 mRNA CTD PMID:18301726 folic acid multiple interactions ISO RGD:1617544 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of NRN1 mRNA] CTD PMID:22206623 fonofos increases methylation ISO RGD:1351872 6480464 Fonofos results in increased methylation of NRN1 promoter CTD PMID:22847954 formaldehyde decreases expression ISO RGD:1351872 6480464 Formaldehyde results in decreased expression of NRN1 mRNA CTD PMID:23649840 genistein affects expression ISO RGD:1617544 6480464 Genistein affects the expression of NRN1 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of NRN1 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:1351872 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA CTD PMID:28628672 methyl methanesulfonate decreases expression ISO RGD:1351872 6480464 Methyl Methanesulfonate results in decreased expression of NRN1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1351872 6480464 methylmercuric chloride results in increased expression of NRN1 mRNA CTD PMID:34089799 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1617544 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of NRN1 mRNA CTD PMID:22401849 morphine decreases expression ISO RGD:1617544 6480464 Morphine results in decreased expression of NRN1 mRNA CTD PMID:21955143 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NRN1 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO RGD:1617544 6480464 Diethylnitrosamine results in increased expression of NRN1 mRNA CTD PMID:17942915 N-nitrosodiethylamine multiple interactions ISO RGD:1617544 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NRN1 mRNA] CTD PMID:17942915 nicotine decreases expression ISO RGD:1617544 6480464 Nicotine results in decreased expression of NRN1 mRNA CTD PMID:21955143 ozone decreases expression ISO RGD:1617544 6480464 Ozone results in decreased expression of NRN1 mRNA CTD PMID:17095637 ozone multiple interactions ISO RGD:1617544 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NRN1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NRN1 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1617544 6480464 Acetaminophen results in increased expression of NRN1 mRNA CTD PMID:29246445 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NRN1 mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1617544 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of NRN1 mRNA] CTD PMID:29246445 parathion increases methylation ISO RGD:1351872 6480464 Parathion results in increased methylation of NRN1 promoter CTD PMID:22847954 pirinixic acid decreases expression ISO RGD:1617544 6480464 pirinixic acid results in decreased expression of NRN1 mRNA CTD PMID:23811191 potassium chromate decreases expression ISO RGD:1351872 6480464 potassium chromate(VI) results in decreased expression of NRN1 mRNA CTD PMID:22714537 SB 431542 multiple interactions ISO RGD:1351872 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRN1 mRNA CTD PMID:27188386 sodium arsenite affects methylation ISO RGD:1351872 6480464 sodium arsenite affects the methylation of NRN1 gene CTD PMID:28589171 terbufos increases methylation ISO RGD:1351872 6480464 terbufos results in increased methylation of NRN1 promoter CTD PMID:22847954 Testosterone propionate increases expression EXP 6480464 Testosterone Propionate results in increased expression of NRN1 mRNA CTD PMID:19427307 titanium dioxide decreases expression ISO RGD:1617544 6480464 titanium dioxide results in decreased expression of NRN1 mRNA CTD PMID:27760801 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of NRN1 mRNA CTD PMID:33387578 trimellitic anhydride decreases expression ISO RGD:1617544 6480464 trimellitic anhydride results in decreased expression of NRN1 mRNA CTD PMID:19042947 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1351872 6480464 tris(2-butoxyethyl) phosphate affects the expression of NRN1 mRNA CTD PMID:29024780 undecane increases expression EXP 6480464 undecane results in increased expression of NRN1 protein CTD PMID:17337753 valproic acid decreases expression ISO RGD:1351872 6480464 Valproic Acid results in decreased expression of NRN1 mRNA CTD PMID:23179753 valproic acid multiple interactions ISO RGD:1351872 6480464 CEBPA protein affects the reaction [Valproic Acid results in increased expression of NRN1 mRNA] CTD PMID:32623605 valproic acid increases expression ISO RGD:1351872 6480464 Valproic Acid results in increased expression of NRN1 mRNA CTD PMID:28001369 , PMID:32623605 valproic acid affects expression ISO RGD:1351872 6480464 Valproic Acid affects the expression of NRN1 mRNA CTD PMID:25979313 vincristine decreases expression ISO RGD:1351872 6480464 Vincristine results in decreased expression of NRN1 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1351872 6480464 vorinostat results in decreased expression of NRN1 mRNA CTD PMID:27188386 vorinostat multiple interactions ISO RGD:1351872 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRN1 mRNA CTD PMID:27188386